Scholars Central

Search Scholars Central

Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.

Advanced searchHide advanced search

In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:

Years

26–50 of 62 articles for Lenalidomide

Then save them, add them to a collection or cite them together.
  1. Conference abstract · 29 Jun 2017

    Oncogenic cytokine signaling in human lymphoma

    suppressed by IRF4 in ABC DLBCL cells. This pathway can be activated by Lenalidomide due to inhibition of IRF4 expression. Based on these findings, we performed in vitro cell survival ... assay and found that…

  2. Conference abstract · 17 Oct 2016

    Teaching an old dog new trick: Genetic profiling predicts response in elderly acute myeloid leukemia treated with old/new drugs combos

    Journal of Hematology & Thromboembolic Diseases

    needed. We hypothesized that the addition of tosedostat, a new amino peptidase inhibitor, or lenalidomide, to low dose cytarabine may improve response over what expected with chemotherapy or tosedostat alone…

  3. Conference abstract · 29 Jun 2020

    Neurology Congress 2020: Symptomatic cauda equina picture with encephalitic changes on EEG in a patient with primary cutaneous diffuse large B cell lymphoma: Case report - Zeeshan Yousuf - University Hospitals Birmingham

    Insights in Neurosurgery · Volume 4, Issue 2

    HGBL-DH. Given the high risk of relapse of disease, maintenance therapy using lenalidomide or venetoclax was attempted and has had positive results, but there is no recommended primary therapy

  4. Editorial · 16 Jun 2020

    Market Analysis of Cancer Surgery

    Cancer Surgery · Volume 5, Issue 1

    owing to the face that it received a breakthrough therapy designation. Revlimid (lenalidomide) belongs to the class of immunomodulatory drugs. It is an oral cancer drug indicated for multiple myeloma

  5. Research article · 10 Jul 2017

    Cure of Insulin-Dependent Diabetes Mellitus by an Autologous Hematopoietic Stem Cell Transplantation Performed to Control Multiple Myeloma in a Patient with Chronic Renal Failure on Regular Hemodialysis

    Journal of Stem Cell Biology and Transplantation · Volume 1, Issue 2

    insulin per day to control his diabetes. After receiving 4 cycles of bortezomib, lenalidomide and dexamethasone, his myeloma was controlled then in March 2013, an autologous hematopoietic stem cell transplantation

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels